DiaSorin S.p.A (DSRLF PINK) stock market data APIs
$66.8976
0(0%)
as of November 7, 2025
Try our APIs with
free plan!
DiaSorin S.p.A Financial Data Overview
Price chart is built with
Anychart
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Prev. Close
66.8976
Open
66.8976
High
66.8976
Low
66.8976
52 wk Range
66.65-112.3
Market Cap
3 741 M
P/E Ratio
16.7043
Shares Outstanding
53 943 K
Revenue
1 209 M
Dividends (Yield)
0.0203
Beta
0.527
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DiaSorin S.p.A data using free add-ons & libraries
Get DiaSorin S.p.A Fundamental Data
DiaSorin S.p.A Fundamental data includes:
- Net Revenue: 1 209 M
- EBITDA: 370 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.99
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DiaSorin S.p.A News
New
Diasorin SpA (FRA:34D) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Market Challenges
This article first appeared on GuruFocus. Year-to-Date Revenue: 900 million, reflecting a 3% increase compared to the same period last year. COVID Sales Impact: $11 million reduction in COVID sales. ...
DiaSorin S.p.A. (DIA): 2025 Product Pipeline and Strategy Analysis Report
Company Logo Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "DiaSorin S.p.A. (DIA) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. DiaSorin's immunodia...
Should Investors Reassess DiaSorin After 50% Five-Year Share Price Slide?
Thinking about what to do with DiaSorin stock right now? You are definitely not alone. With the share price recently closing at 79.14, it is no surprise many investors are re-examining their positions...
Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies
Company Logo The Europe proteomics market is expected to rise to $27.43 billion by 2034 from $8.77 billion in 2024, with a CAGR of 12.07%. Driving this growth are advancements in mass spectrometry an...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
